de Bruijne EL - Search Results

Year	Number of Results
1995	1
1999	1
2005	1
2006	1
2007	2
2008	2
2009	3
2010	1
2011	2
2013	1
2014	1
2023	1
2024	1

1

Antihypertensive drug concentration measurement combined with personalized feedback in resistant hypertension: a randomized controlled trial.

Peeters LEJ, Kappers MHW, Hesselink DA, van der Net JB, Hartong SCC, van de Laar R, Ezzahti M, van de Ven PJG, van der Meer IM, de Bruijne ELE, Kroon AA, Indhirajanti-Tomasoa S, van der Linde NAJ, Bahmany S, Boersma E, Massey EK, van Dijk L, van Gelder T, Koch BCP, Versmissen J. Peeters LEJ, et al. Among authors: de bruijne ele. J Hypertens. 2024 Jan 1;42(1):169-178. doi: 10.1097/HJH.0000000000003585. Epub 2023 Oct 18. J Hypertens. 2024. PMID: 37796233 Free PMC article. Clinical Trial.

2

Determinants of blood pressure reduction by eplerenone in uncontrolled hypertension.

Jansen PM, Frenkel WJ, van den Born BJ, de Bruijne EL, Deinum J, Kerstens MN, Arnoldus JH, Woittiez AJ, Wijbenga JA, Zietse R, Danser AH, van den Meiracker AH. Jansen PM, et al. Among authors: de bruijne el. J Hypertens. 2013 Feb;31(2):404-13. doi: 10.1097/HJH.0b013e32835b71d6. J Hypertens. 2013. PMID: 23249826

3

Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism.

Jansen PM, van den Born BJ, Frenkel WJ, de Bruijne EL, Deinum J, Kerstens MN, Smulders YM, Woittiez AJ, Wijbenga JA, Zietse R, Danser AH, van den Meiracker AH. Jansen PM, et al. Among authors: de bruijne el. J Hypertens. 2014 Jan;32(1):115-26. doi: 10.1097/HJH.0b013e3283656b54. J Hypertens. 2014. PMID: 24018605

4

Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients.

Bongers TN, de Bruijne EL, Dippel DW, de Jong AJ, Deckers JW, Poldermans D, de Maat MP, Leebeek FW. Bongers TN, et al. Among authors: de bruijne el. Atherosclerosis. 2009 Nov;207(1):250-4. doi: 10.1016/j.atherosclerosis.2009.04.013. Epub 2009 Apr 17. Atherosclerosis. 2009. PMID: 19439298

5

High thrombin activatable fibrinolysis inhibitor levels are associated with an increased risk of premature peripheral arterial disease.

de Bruijne EL, Gils A, Rijken DC, de Maat MP, Guimarães AH, Poldermans D, Declerck PJ, Leebeek FW. de Bruijne EL, et al. Thromb Res. 2011 Mar;127(3):254-8. doi: 10.1016/j.thromres.2010.11.026. Epub 2010 Dec 30. Thromb Res. 2011. PMID: 21195459 Free article.

6

The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis.

Martini CH, Brandts A, de Bruijne EL, van Hylckama Vlieg A, Leebeek FW, Lisman T, Rosendaal FR. Martini CH, et al. Among authors: de bruijne el. Br J Haematol. 2006 Jul;134(1):92-4. doi: 10.1111/j.1365-2141.2006.06117.x. Br J Haematol. 2006. PMID: 16803573 Free article.

7

The effect of nitric oxide donors on haemodynamics and blood flow distribution in the porcine carotid circulation.

van Gelderen EM, De Bruijne EL, Agteresch HJ, Saxena PR. van Gelderen EM, et al. Among authors: de bruijne el. Br J Pharmacol. 1995 Mar;114(6):1303-9. doi: 10.1111/j.1476-5381.1995.tb13347.x. Br J Pharmacol. 1995. PMID: 7620722 Free PMC article.

8

Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children.

Emonts M, de Bruijne EL, Guimarães AH, Declerck PJ, Leebeek FW, de Maat MP, Rijken DC, Hazelzet JA, Gils A. Emonts M, et al. Among authors: de bruijne el. J Thromb Haemost. 2008 Feb;6(2):268-76. doi: 10.1111/j.1538-7836.2008.02841.x. Epub 2007 Nov 15. J Thromb Haemost. 2008. PMID: 18021301 Free article.

9

The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study.

de Bruijne EL, Gils A, Guimarães AH, Dippel DW, Deckers JW, van den Meiracker AH, Poldermans D, Rijken DC, Declerck PJ, de Maat MP, Leebeek FW. de Bruijne EL, et al. J Thromb Haemost. 2009 Jun;7(6):919-27. doi: 10.1111/j.1538-7836.2009.03350.x. Epub 2009 Mar 23. J Thromb Haemost. 2009. PMID: 19323787 Free article.

10

Hypofibrinolysis is a risk factor for arterial thrombosis at young age.

Guimarães AH, de Bruijne EL, Lisman T, Dippel DW, Deckers JW, Poldermans D, Rijken DC, Leebeek FW. Guimarães AH, et al. Among authors: de bruijne el. Br J Haematol. 2009 Apr;145(1):115-20. doi: 10.1111/j.1365-2141.2008.07568.x. Epub 2009 Jan 30. Br J Haematol. 2009. PMID: 19183334 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year